Clinical Trial Update: Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating gevokizumab for moderate-to-severe acne vulgaris has completed; the update covers efficacy and safety findings.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• Gevokizumab (gevokizumab)

Snippet

Sponsor: XOMA (US) LLC | Conditions: Acne Vulgaris | Phase 2 | Status: COMPLETED